Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
09/18/1997 | WO1997033877A1 Bioconjugates of manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
09/18/1997 | WO1997033623A1 OLIGONUCLEOTIDES TARGETED TO ANGIOTENSINOGEN mRNA |
09/18/1997 | WO1997033609A1 VASOACTIVE EFFECTS AND FREE RADICAL GENERATION BY β-AMYLOID PEPTIDES |
09/18/1997 | WO1997033608A2 Antagonism of endothelin actions |
09/18/1997 | WO1997033588A1 Iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
09/18/1997 | WO1997033570A1 Dosage forms and uses |
09/18/1997 | WO1997033552A1 Water soluble paclitaxel prodrugs |
09/18/1997 | WO1997025440A3 Methods and compositions for diagnosis of hyperhomocysteinemia |
09/18/1997 | WO1997025343A3 Antithrombotic agents and methods of use |
09/18/1997 | CA2249733A1 Spirocycle integrin inhibitors |
09/18/1997 | CA2249011A1 Bioconjugates of manganese or iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
09/18/1997 | CA2248964A1 Iron complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
09/18/1997 | CA2248932A1 Oligonucleotides targeted to angiotensinogen mrna |
09/18/1997 | CA2248927A1 Smooth muscle cell lim protein |
09/18/1997 | CA2248613A1 Vasoactive effects and free radical generation by .beta.-amyloid peptides |
09/18/1997 | CA2248586A1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
09/18/1997 | CA2248549A1 Extracellular matrix signalling molecules |
09/18/1997 | CA2247888A1 Human bikunin |
09/18/1997 | CA2225913A1 Persephin and related growth factors |
09/17/1997 | EP0795556A1 4-Substituted pyrrolopyrimidine compounds as tyrosin kinase inhibitors |
09/17/1997 | EP0795327A1 Use of Amlodipine for the treatment and prophylaxis of congestive cardiac failure of non-ischaemic origin |
09/17/1997 | EP0794965A1 Factor vii fragment 82-128 and its use in blood-clotting disorders |
09/17/1997 | EP0794955A1 Hindered n-oxide esters of rapamycin and their use as medicaments |
09/17/1997 | EP0794949A1 Novel 3,5-dioxo-(2h,4h)-1,2,4-triazine derivatives, their preparation and use as drugs |
09/17/1997 | EP0794944A1 Perhydroisoindole derivatives as antagonists of substance p |
09/17/1997 | EP0794942A1 Substituted biphenyl compounds for the treatment of inflammation |
09/17/1997 | EP0794774A1 4,4-(disubstituted)cyclohexan-1-ols monomers and related compounds |
09/17/1997 | EP0707475B1 Extended release, film-coated tablet of astemizole and pseudoephedrine |
09/17/1997 | EP0683773B1 Hypolipidaemic condensed 1,4-thiazepines |
09/17/1997 | EP0655057B1 Cyanoguanidines as potassium channel blockers |
09/17/1997 | EP0635009B1 Novel derivatives of 2,3-dihydro-2,2,4,6,7-pentaalkyl-5-benzofuranols |
09/17/1997 | EP0525123B1 Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones |
09/17/1997 | CN1159828A Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin |
09/17/1997 | CN1159807A New heterocyclic substituted imidazoloquinoxalinones their preparation and their use |
09/17/1997 | CN1159805A Nvel imidazole derivatives, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
09/17/1997 | CN1159804A Dihydrobenzofuranes |
09/17/1997 | CN1159797A Aryloxy and arylthiopropanolamine derivative suseful as beta 3-adrenoreceptor agonists and antagonists of the beta 1 and beta 2-adrenoreceptors and pharmaceutical composition thereof |
09/17/1997 | CN1159448A Benzothiophene compounds, intermediates, compositions, and methods |
09/17/1997 | CN1159444A Sulfuryl amino substituted benzoyl guanidine, preparation process and applications as medicine or diagnostic agent and the medicine containing same |
09/17/1997 | CN1159332A Cap for preventing and curing cerebral hemorrhage |
09/16/1997 | US5668162 Isothiazolones lower plasma levels of lipoprotein(a) |
09/16/1997 | US5668158 Cyclic amino acid derivatives |
09/16/1997 | US5668157 Cyanoguanidines as K-channel blockers |
09/16/1997 | US5668152 Protein kinase C inhibitors |
09/16/1997 | US5668151 Useful as anorexigenic agents in promoting weight loss and treating eating disorders |
09/16/1997 | US5668143 Heterocyclic benzenesulfonylimine derivatives as inhibitors of IL-1 action |
09/16/1997 | US5668139 Xanthine derivatives |
09/16/1997 | US5668137 N-heterocyclic sulfonamides having endothelin receptor activity |
09/16/1997 | US5668136 Trisubstituted benzene derivatives, composition and methods of treatment |
09/16/1997 | US5668125 Spironolactone |
09/16/1997 | US5668124 Use of aldosterone antagonists to inhibit myocardial fibrosis |
09/16/1997 | US5668123 Method of maintaining remission from venous ulcers with sulphasalazine and its metabolite |
09/16/1997 | US5668117 Nervous system disorders using aromatic acid compounds |
09/16/1997 | US5668012 Platelet endothelial cell adhesion molecule-1 promoters and uses thereof |
09/16/1997 | US5667774 Crosslinked polymeric ammonium salts |
09/15/1997 | CA2199888A1 Method for improving morbidity and/or mortality |
09/12/1997 | WO1997032996A1 Direct molecular diagnosis of friedreich ataxia |
09/12/1997 | WO1997032979A1 Inhibition of proliferation of cells |
09/12/1997 | WO1997032883A1 Azolobenzazepine derivatives as neurologically active agents |
09/12/1997 | WO1997032874A1 Novel sulphur derivatives comprising an amide bond, method for preparing same, use thereof as drugs, and pharmaceutical compositions containing such derivatives |
09/12/1997 | WO1997032870A1 2-aminoethyl-benzofuran derivatives, preparation thereof and therapeutical use thereof |
09/12/1997 | WO1997032856A1 4-anilinoquinazoline derivatives |
09/12/1997 | WO1997032855A1 2-thioxotetrahydropyrimidin-4-one derivatives |
09/12/1997 | WO1997032849A1 Sulphur derivatives with a retroamide bond as endothelin-converting enzyme inhibitors |
09/12/1997 | WO1997032844A1 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors |
09/12/1997 | WO1997032585A1 Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor |
09/12/1997 | WO1997032583A1 Use of csaidtm compounds as inhibitors of angiogenesis |
09/12/1997 | WO1997032581A1 Use of 4-phenyl-3,6-dihydro-2h-pyridyl derivatives as nmda receptor subtype blockers |
09/12/1997 | WO1997032575A1 Mercapto derivatives as inhibitors of cyclooxygenases |
09/12/1997 | CA2248350A1 Inhibition of proliferation of cells |
09/12/1997 | CA2248188A1 Sulphur derivatives with a retroamide bond as endothelin-converting enzyme inhibitors |
09/12/1997 | CA2248187A1 Novel sulphur derivatives comprising an amide bond, method for preparing same, use thereof as drugs, and pharmaceutical compositions containing such derivatives |
09/12/1997 | CA2248134A1 Use of 4-phenyl-3,6-dihydro-2h-pyridyl derivatives as nmda receptor subtype blockers |
09/12/1997 | CA2247933A1 2-thioxotetrahydropyrimidin-4-one derivatives |
09/12/1997 | CA2247453A1 Azolobenzazepine derivatives as neurologically active agents |
09/12/1997 | CA2238029A1 Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor |
09/10/1997 | EP0794172A1 Orthosubstituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic agent and a medicament containing them |
09/10/1997 | EP0794171A2 Orthosubstituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic material and medicaments containing them |
09/10/1997 | EP0793962A1 Medicament containing a carnitine derivative for treating arteriosclerosis obliterans |
09/10/1997 | EP0793674A1 Human neutrophil elastase inhibitors |
09/10/1997 | EP0793658A1 Oxazole derivatives as antagonists of alpha-1c adrenergic receptors |
09/10/1997 | EP0793641A1 Metalloproteinase inhibitors |
09/10/1997 | EP0793500A1 Pharmaceutical compositions comprising nitric oxide-releasing biopolymers |
09/10/1997 | EP0793492A1 Treating disorders characterised by excessive cell proliferation with sclareolide |
09/10/1997 | EP0793490A1 Compositions of tocopherol and beta-carotene |
09/10/1997 | EP0664807B1 Quinoxalinedione derivatives as eaa antagonists |
09/10/1997 | EP0640070B1 Styryl derivatives, their preparation and use as pde-iv inhibitors |
09/10/1997 | EP0636140B1 Partially modified and retro-inverted tetrapeptides analogues of c-reactive protein fragments |
09/10/1997 | EP0586405B1 NOVEL 2H-BENZO[b]PYRANE DERIVATIVES SUBSTITUTED IN THE 4 POSITION BY ARYL OR N-HETEROARYL, PROCESS FOR PRODUCING THEM AND PREPARATIONS CONTAINING THE COMPOUNDS |
09/10/1997 | EP0566644B1 Method of removing endotoxins |
09/10/1997 | CN1158855A Alkylxanthine phosphonates and alkylxanthine phosphine oxides and their use as pharmacueticals |
09/10/1997 | CN1158844A Tertiary amines |
09/10/1997 | CN1158725A Use of 8,9-dehydroestrone as antioxidant |
09/09/1997 | US5665883 Treatment of pain, inflammation, migraine, emesis |
09/09/1997 | US5665768 Heteroaryl cycloalkenyl hydroxyureas |
09/09/1997 | US5665766 Ester of an organic nitrate and a salicylate |
09/09/1997 | US5665758 6-Heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[CD] indoles |
09/09/1997 | US5665749 For treating inflammation, allergies or cardiovascular diseases in mammals |
09/09/1997 | US5665748 Antidiabetic, hypolipidemic agents |
09/09/1997 | US5665747 Treating nervous system, psychological, and brain disorders |